构建“产学研用”一体化，英氏控股以科研驱动辅食精准升级

Core Viewpoint - The article highlights the advancements and innovations by Ying's Holdings in the infant nutrition sector, particularly focusing on the importance of unsaturated fatty acids for infant development and the company's commitment to scientific research and product innovation [1][6]. Group 1: Scientific Insights - Dr. Wang Xiong from Ying's Holdings presented a report at the 10th China Special Food Conference, emphasizing the critical role of unsaturated fatty acids in infant neurological and visual development, as well as immune regulation [1][6]. - The report pointed out a common dietary gap in the intake of nutrients like alpha-linolenic acid [1][6]. Group 2: Product Innovation - Ying's Holdings has evolved its cooking oil products from a standard edible oil (1.0) to a functional enhancement oil (2.0), and now to a precision formula oil (3.0), showcasing a research-driven approach to meet infant nutritional needs [3][8]. - The company has made significant advancements in rice flour products, utilizing starch enzyme technology to create smaller, more digestible molecules, thus easing the digestive burden on infants [4][8]. Group 3: Research and Development - Ying's Holdings has established a comprehensive research support system, collaborating with institutions like the Chinese Academy of Engineering and Hunan University of Traditional Chinese Medicine [4][8]. - In 2023, the company increased its research investment by constructing the Ying's Infant Nutrition and Health Science Industrial Base, set to be fully operational by the end of 2024, focusing on staged rice flour production [4][9]. - Dr. Ren Guopu has been appointed as the chief scientist to lead foundational research projects, particularly in developing a scientific feeding system for infant complementary foods [9][10]. Group 4: Future Outlook - The establishment of the postdoctoral innovation and entrepreneurship practice base at Ying's Holdings aims to foster talent development and continuous research innovation in the industry [5][10]. - The company plans to leverage its research advantages to deepen product innovation and maintain its leading position in the infant health sector, contributing to the high-quality development of maternal and infant health in China [5][10].